52 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
ended December 31, 2023 and December 31, 2022.
Name and
Principal Position
Year
Salary
Bonus
Stock
Awards
($)(1)
Option
Awards
($)(2)
Non-equity … an additional $15,590, which is equal to 9.061% of the cash bonus earned by Dr. Moebius during 2023. The reported amount for 2022 includes monthly cash
8-K
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
salary at a rate of US$465,000 per year, remain eligible to participate in the Company’s fiscal 2023 bonus program with a target bonus amount equal … to 40% of his annual base salary and to receive a stipend equal to 9.06% of his fiscal 2023 bonus, if any, will be eligible for the continued vesting
8-K
EX-10.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
to Executive.
(e)2023 Bonus. Executive shall be eligible for an annual bonus corresponding to fiscal year 2023, which, if awarded, will be based upon … Bonus”). The target amount of the 2023 Bonus will be 40% of the Base Salary (the “Target Bonus Amount”). The Company’s Board of Directors (the “Board
8-K
731n3
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.1
vheq705v mcq48l
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.2
bsz2yf88wc2i07aa
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-3.1
phwrs w766
18 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
DFAN14A
EX-99.2
efvmz8c92 p9496x4de
27 Apr 22
Additional proxy materials by non-management
2:39pm
DFAN14A
EX-99.3
hbsc8pg7l7n 8zrayxcm
22 Apr 22
Additional proxy materials by non-management
10:07am
DFAN14A
EX-99.4
b6xpfz 8g3qxn4fyf8ec
22 Apr 22
Additional proxy materials by non-management
10:07am
DFAN14A
EX-99.8
cucqeop
22 Apr 22
Additional proxy materials by non-management
10:07am
DEFC14A
rqr7s6 as38p5ywkut0p
5 Apr 22
Proxy in contested solicitation
4:08pm
DFAN14A
wq83k8hx s4o0
30 Mar 22
Additional proxy materials by non-management
10:21am
PREC14A
uwsrnm3esh6fsri0ddfg
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
8-K
g755q9j3xtffkl
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm